Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Nivolumab Switch Maintenance Therapy after Tyrosine Kinase Inhibitor Induction in Metastatic Renal Cell Carcinoma: A Randomized Clinical Trial by the Interdisciplinary Working Group on Renal Tumors of the German Cancer Society (NIVOSWITCH; AIO-NZK-0116ass).

Viktor Gruenwald,Philipp Ivanyi,Stefanie Zschaebitz,Manfred Wirth,Peter Staib,Martin Schostak,Philip Dargatz,Lothar Mueller,Michael Metz,Lothar Bergmann,Thomas Steiner,Martin Welslau,Anja Lorch,Reza Rafiyan,Eva Hellmis,Cristopher Darr,Philipp Schuett,Johannes Meiler,Thomas Kretz,Wolfgang Loidl,Anne Floercken,Martin Maenz,Axel Hinke,Arndt Hartmann,Carsten Gruellich

European Urology（2023）

Cited 2|Views48
Key words
Metastatic renal cell carcinoma,Nivolumab,Tyrosine kinase inhibitor,Switch maintenance therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined